Skip to content
My dad, a Southern protestant minister, preached a variation of the same sermon nearly every Sunday. As a child, I struggled to stay awake. […]
We’ll never go hungry – if we support innovation Read More »
Louisiana sugar cane replaces crude oil in a down hoody coat that keeps you warm while reducing your environmental footprint. Patagonia, the major clothing
Patagonia launches sweet new down coat made with bio-material Read More »
Start-ups looking to present their innovations in front of the biggest annual gathering of the biotech community can apply now for the Start-up Stadium
Start-up Stadium introduces biotech innovators and investors Read More »
A new study based on insurance claims found that the consistently rising temperatures brought on by climate change are increasing instances of heat-related health
Climate change makes us sicker, finds review of insurance claims Read More »
At 30-years old, the 340B program is buckling under its own weight and overdue for reform. With legal action, including a Supreme Court ruling,
The 30-year-old 340B drug discount program is due for reform Read More »
American Gene Technologies (AGT) calls its gene therapy, AGT103-T, a “potential cure” for HIV. The drug met “the primary and secondary endpoints of its
AGT says gene therapy is a ‘potential cure’ for HIV Read More »
Novavax, a biotech company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced the initiation of a phase 2 trial for
Novavax announces phase 2 trial for combined COVID/flu vaccine Read More »
With an alarming global inflation rate and businesses generating lower revenues, the economic situation is also affecting biotech investment. But biotech is one industry
Biotech might beat inflation, offer hope for investors Read More »
Study the past, if you would define the future, Confucius once said. Staying true to this maxim, researchers delving deeper into the secrets of
2-million-year-old DNA could show solutions to future climate challenges Read More »
Vertex Pharmaceuticals Incorporated and Entrada Therapeutics, Inc. have formed a global partnership to find and develop treatments for myotonic dystrophy type 1 (DM1), a
Vertex partners with Entrada on new approach for muscle dystrophy treatment Read More »
